Cargando…

Microbiota biliar en pacientes colecistectomizados: Revisión de la antibioterapia empírica

INTRODUCTION: Cholecystitis is an important cause of hospital admission. In moderate or severe cholecystitis, the delay in treatment can lead to serious complications. Our objective is to analyze the microorganisms isolated in bile from cholecystectomized patients and their sensitivity pattern, to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Fortuño, María Gil, Villach, Laura Granel, Vidal, Susana Sabater, Martín, Raquel Soria, Ramos, David Martínez, Sos, Javier Escrig, Muñoz, Rosario Moreno, Adell, Rafael Igual
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Quimioterapia 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790889/
https://www.ncbi.nlm.nih.gov/pubmed/31531672
_version_ 1783458863171764224
author Fortuño, María Gil
Villach, Laura Granel
Vidal, Susana Sabater
Martín, Raquel Soria
Ramos, David Martínez
Sos, Javier Escrig
Muñoz, Rosario Moreno
Adell, Rafael Igual
author_facet Fortuño, María Gil
Villach, Laura Granel
Vidal, Susana Sabater
Martín, Raquel Soria
Ramos, David Martínez
Sos, Javier Escrig
Muñoz, Rosario Moreno
Adell, Rafael Igual
author_sort Fortuño, María Gil
collection PubMed
description INTRODUCTION: Cholecystitis is an important cause of hospital admission. In moderate or severe cholecystitis, the delay in treatment can lead to serious complications. Our objective is to analyze the microorganisms isolated in bile from cholecystectomized patients and their sensitivity pattern, to evaluate the empirical treatment in those cases in which the surgical removal of the gallbladder should be delayed. PATIENTS AND METHODS: Prospective descriptive study of biliary cultures of patients undergoing cholecystectomy from May 2013 to February 2015, in the Surgery Department of the Hospital General Universitari de Castelló. RESULTS: We studied 196 patients, 83 women (42.3%) and 113 men (57.7%), with an average age of 61.5 years. The most used antibiotics as empiric treatment were piperacillin/tazobactam (77.8%) and amoxicillin/clavulanic (14.8%). In 46.4% of patients (91/196) bile cultures were positive. 165 microorganisms were isolated. The majority were Gram-negative bacilli (60.5%), mainly of the Enterobacterales order (91/54.5%), with Escherichia coli being the most frequent microorganism (24%) followed by Klebsiella spp. (12.5%). 3 E. coli with extended-spectrum beta-lactamase (ESBL) and 1 K. pneumoniae with ESBL were isolated. Microorganisms producing carbapenemase and methicillin-resistant Staphylococcus aureus were not isolated. CONCLUSION: The bile microbiota, with a predominance of Enterobacterales is similar to that found in european studies.
format Online
Article
Text
id pubmed-6790889
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Sociedad Española de Quimioterapia
record_format MEDLINE/PubMed
spelling pubmed-67908892019-10-25 Microbiota biliar en pacientes colecistectomizados: Revisión de la antibioterapia empírica Fortuño, María Gil Villach, Laura Granel Vidal, Susana Sabater Martín, Raquel Soria Ramos, David Martínez Sos, Javier Escrig Muñoz, Rosario Moreno Adell, Rafael Igual Rev Esp Quimioter Original INTRODUCTION: Cholecystitis is an important cause of hospital admission. In moderate or severe cholecystitis, the delay in treatment can lead to serious complications. Our objective is to analyze the microorganisms isolated in bile from cholecystectomized patients and their sensitivity pattern, to evaluate the empirical treatment in those cases in which the surgical removal of the gallbladder should be delayed. PATIENTS AND METHODS: Prospective descriptive study of biliary cultures of patients undergoing cholecystectomy from May 2013 to February 2015, in the Surgery Department of the Hospital General Universitari de Castelló. RESULTS: We studied 196 patients, 83 women (42.3%) and 113 men (57.7%), with an average age of 61.5 years. The most used antibiotics as empiric treatment were piperacillin/tazobactam (77.8%) and amoxicillin/clavulanic (14.8%). In 46.4% of patients (91/196) bile cultures were positive. 165 microorganisms were isolated. The majority were Gram-negative bacilli (60.5%), mainly of the Enterobacterales order (91/54.5%), with Escherichia coli being the most frequent microorganism (24%) followed by Klebsiella spp. (12.5%). 3 E. coli with extended-spectrum beta-lactamase (ESBL) and 1 K. pneumoniae with ESBL were isolated. Microorganisms producing carbapenemase and methicillin-resistant Staphylococcus aureus were not isolated. CONCLUSION: The bile microbiota, with a predominance of Enterobacterales is similar to that found in european studies. Sociedad Española de Quimioterapia 2019-09-27 2019 /pmc/articles/PMC6790889/ /pubmed/31531672 Text en © The Author 2019 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).
spellingShingle Original
Fortuño, María Gil
Villach, Laura Granel
Vidal, Susana Sabater
Martín, Raquel Soria
Ramos, David Martínez
Sos, Javier Escrig
Muñoz, Rosario Moreno
Adell, Rafael Igual
Microbiota biliar en pacientes colecistectomizados: Revisión de la antibioterapia empírica
title Microbiota biliar en pacientes colecistectomizados: Revisión de la antibioterapia empírica
title_full Microbiota biliar en pacientes colecistectomizados: Revisión de la antibioterapia empírica
title_fullStr Microbiota biliar en pacientes colecistectomizados: Revisión de la antibioterapia empírica
title_full_unstemmed Microbiota biliar en pacientes colecistectomizados: Revisión de la antibioterapia empírica
title_short Microbiota biliar en pacientes colecistectomizados: Revisión de la antibioterapia empírica
title_sort microbiota biliar en pacientes colecistectomizados: revisión de la antibioterapia empírica
topic Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790889/
https://www.ncbi.nlm.nih.gov/pubmed/31531672
work_keys_str_mv AT fortunomariagil microbiotabiliarenpacientescolecistectomizadosrevisiondelaantibioterapiaempirica
AT villachlauragranel microbiotabiliarenpacientescolecistectomizadosrevisiondelaantibioterapiaempirica
AT vidalsusanasabater microbiotabiliarenpacientescolecistectomizadosrevisiondelaantibioterapiaempirica
AT martinraquelsoria microbiotabiliarenpacientescolecistectomizadosrevisiondelaantibioterapiaempirica
AT ramosdavidmartinez microbiotabiliarenpacientescolecistectomizadosrevisiondelaantibioterapiaempirica
AT sosjavierescrig microbiotabiliarenpacientescolecistectomizadosrevisiondelaantibioterapiaempirica
AT munozrosariomoreno microbiotabiliarenpacientescolecistectomizadosrevisiondelaantibioterapiaempirica
AT adellrafaeligual microbiotabiliarenpacientescolecistectomizadosrevisiondelaantibioterapiaempirica